|
|
| (One intermediate revision by the same user not shown) |
| Line 13: |
Line 13: |
| | ===Source=== | | ===Source=== |
| | | | |
| − | This sequence was acquired from S. aureus. | + | This sequence was acquired from <i>S. aureus</i>. |
| − | | + | |
| − | ===References===
| + | |
| − | El-Halfawy, O. M., Czarny, T. L., Flannagan, R. S., Day, J., Bozelli, J. C., Kuiack, R. C., Salim, A., Eckert, P., Epand, R. M., McGavin, M. J., Organ, M. G., Heinrichs, D. E., & Brown, E. D. (2020). Discovery of an antivirulence compound that reverses β-lactam resistance in MRSA. <i>Nature Chemical Biology</i>, 16(2), 143–149. https://doi.org/10.1038/s41589-019-0401-8
| + | |
| − | | + | |
| − | Falord, M., Mäder, U., Hiron, A., Débarbouillé, M., & Msadek, T. (2011). Investigation of the Staphylococcus aureus GraSR Regulon Reveals Novel Links to Virulence, Stress Response and Cell Wall Signal Transduction Pathways. <i>PLoS ONE</i>, 6(7), e21323. https://doi.org/10.1371/journal.pone.0021323
| + | |
| − | | + | |
| − | Meehl, M., Herbert, S., Götz, F., & Cheung, A. (2007). Interaction of the GraRS Two-Component System with the VraFG ABC Transporter To Support Vancomycin-Intermediate Resistance in Staphylococcus aureus. <I> Antimicrobial Agents and Chemotherapy </i>, 51(8), 2679–2689. https://doi.org/10.1128/AAC.00209-07
| + | |
| − | | + | |
| − | Yang, S.-J., Bayer, A. S., Mishra, N. N., Meehl, M., Ledala, N., Yeaman, M. R., Xiong, Y. Q., & Cheung, A. L. (2012). The Staphylococcus aureus Two-Component Regulatory System, GraRS, Senses and Confers Resistance to Selected Cationic Antimicrobial Peptides. <I> Infection and Immunity</i>, 80(1), 74–81. https://doi.org/10.1128/IAI.05669-11
| + | |
This sequence was codon optimised for human cell lines.
